BioTactics in Action: Start Page

Vol. 1, Issue 1
May 1998 

Home
Index of Issues
Site Map
Contact Us

Subscribe/
Unsubscribe

Online Newsletter for
Biotech Marketing and Business Development

Please visit this month's sponsor: Celebrus Consulting Group

Contents:

Competitive Intellegence: Resources on the Web, Sharon Locken, President, Locken Information.

More Sales and Profits from Existing Customers.
Cay Villars, President, Market Value Concepts.

Importance of Brand: Research Products. Bill Kelly, President, BioInformatics.

Consolidation: New Marketing Strategies in Research Products.  An interview with Bruce Lehman, President, Lehman Millet, Inc.

BioTactics Parners program - how it benefits your business.

New Job Postings

border.gif (871 bytes) Marketing to Life Scientists: The Importance of Brand
by Bill Kelly, BioInformatics, Inc.    (Continued, Page 2.)
wpe33.jpg (866 bytes)

wpe33.jpg (866 bytes)

w.gif (1004 bytes)e came to the conclusion that the Life Sciences market provides a textbook example of the importance of building "brand equity," and this has enormous implications for managers seeking to maximize the impact of their marketing efforts. Brand equity is defined as the customers' perception of a brand's value, and is generally considered to be composed of five major elements:
  • Brand awareness
  • Brand loyalty
  • Competitive advantage
  • Perceived quality/Value
  • Brand association

i.gif (879 bytes)n the Life Sciences market, brand equity grows from your customer's successive satisfactory experiences with your products and services, supported by the recommendations and experiences of colleagues. In time, a true brand becomes the "only" source of a product in the mind of the customer. Moreover, if brand equity is developed and managed properly, it is far easier to introduce new products to the market successfully.

A.gif (947 bytes) marketing program designed to build brand equity has important ramifications for your overall positioning strategy. Many professionals in the Life Sciences market often mistakenly refer to commonly-used products as "commodities." A true commodity, however, is a raw material where only availability affects the market price, and market share invariably migrates to the lowest cost supplier. What are commonly referred to as commodity life science products (e.g., restriction enzymes or classical media), should be referred to as "mature" products.

t.gif (892 bytes)his is not a semantic difference. When a marketing manager treats a mature product as a commodity, he or she may feel the only option is to compete on price. But if one examines the mature products in the Life Sciences market, it becomes apparent that there are wide discrepancies in prices, profit margins and market share. This would not occur in a true commodity market. In fact, what is being observed is brand equity at work. Some vendors are able to charge far higher prices than others, for essentially the same product, simply because of the perceptions, beliefs and behavior exhibited by their customer base. As products mature, effective marketing designed to build brand equity becomes all the more critical.


newsline.jpg (2561 bytes)

| Back | MVC | Home | Email | Discussion | Site Map | Tips | Top of Page | Forward |
| Career | Planning Tools | Network | News | Calendar | Travel | Partners |

BioTactics Reference Web for Marketing and Business Development in Biotech
Sponsored by Market Value Concepts. © Copyright 1997,1998, 1999 Market Value Concepts.
BioTactics and BioTactics in Action are Trademarks of Market Value Concepts.
http://www.biotactics.com/Newsletter/v1i1/Brand2.htm